Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

194 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic.
Korobelnik JF, Loewenstein A, Eldem B, Joussen AM, Koh A, Lambrou GN, Lanzetta P, Li X, Lövestam-Adrian M, Navarro R, Okada AA, Pearce I, Rodríguez FJ, Wong DT, Wu L. Korobelnik JF, et al. Among authors: pearce i. Graefes Arch Clin Exp Ophthalmol. 2020 Jun;258(6):1149-1156. doi: 10.1007/s00417-020-04703-x. Epub 2020 Apr 23. Graefes Arch Clin Exp Ophthalmol. 2020. PMID: 32328757 Free PMC article. Review.
Anti-VEGF intravitreal injections in the era of COVID-19: responding to different levels of epidemic pressure.
Korobelnik JF, Loewenstein A, Eldem B, Joussen AM, Koh A, Lambrou GN, Lanzetta P, Li X, Lövestam-Adrian M, Navarro R, Okada AA, Pearce I, Rodríguez FJ, Wong DT, Wu L. Korobelnik JF, et al. Among authors: pearce i. Graefes Arch Clin Exp Ophthalmol. 2021 Mar;259(3):567-574. doi: 10.1007/s00417-021-05097-0. Epub 2021 Feb 2. Graefes Arch Clin Exp Ophthalmol. 2021. PMID: 33528647 Free PMC article. Review.
Pachychoroid: current concepts on clinical features and pathogenesis.
Castro-Navarro V, Behar-Cohen F, Chang W, Joussen AM, Lai TYY, Navarro R, Pearce I, Yanagi Y, Okada AA. Castro-Navarro V, et al. Among authors: pearce i. Graefes Arch Clin Exp Ophthalmol. 2021 Jun;259(6):1385-1400. doi: 10.1007/s00417-020-04940-0. Epub 2020 Oct 15. Graefes Arch Clin Exp Ophthalmol. 2021. PMID: 33057904 Free PMC article. Review.
Recommendations for OCT Angiography Reporting in Retinal Vascular Disease: A Delphi Approach by International Experts.
Munk MR, Kashani AH, Tadayoni R, Korobelnik JF, Wolf S, Pichi F, Koh A, Ishibazawa A, Gaudric A, Loewenstein A, Lumbroso B, Ferrara D, Sarraf D, Wong DT, Skondra D, Rodriguez FJ, Staurenghi G, Pearce I, Kim JE, Freund KB, Parodi MB, Waheed NK, Rosen R, Spaide RF, Nakao S, Sadda S, Vujosevic S, Wong TY, Murata T, Chakravarthy U, Ogura Y, Huf W, Tian M. Munk MR, et al. Among authors: pearce i. Ophthalmol Retina. 2022 Sep;6(9):753-761. doi: 10.1016/j.oret.2022.02.007. Epub 2022 Feb 22. Ophthalmol Retina. 2022. PMID: 35202889 Free PMC article.
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
Wykoff CC, Abreu F, Adamis AP, Basu K, Eichenbaum DA, Haskova Z, Lin H, Loewenstein A, Mohan S, Pearce IA, Sakamoto T, Schlottmann PG, Silverman D, Sun JK, Wells JA, Willis JR, Tadayoni R; YOSEMITE and RHINE Investigators. Wykoff CC, et al. Lancet. 2022 Feb 19;399(10326):741-755. doi: 10.1016/S0140-6736(22)00018-6. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085503 Clinical Trial.
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
Heier JS, Khanani AM, Quezada Ruiz C, Basu K, Ferrone PJ, Brittain C, Figueroa MS, Lin H, Holz FG, Patel V, Lai TYY, Silverman D, Regillo C, Swaminathan B, Viola F, Cheung CMG, Wong TY; TENAYA and LUCERNE Investigators. Heier JS, et al. Lancet. 2022 Feb 19;399(10326):729-740. doi: 10.1016/S0140-6736(22)00010-1. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085502 Clinical Trial.
194 results